1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one

C25H24FN7O3S — CID 90326598

IUPAC1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one
SMILESCCn1cc(-c2ccc(F)c(N3CCN(c4ccc(S(C)(=O)=O)cc4)C3=O)c2)c(-c2ccnc(N)n2)n1
InChIInChI=1S/C25H24FN7O3S/c1-3-31-15-19(23(30-31)21-10-11-28-24(27)29-21)16-4-9-20(26)22(14-16)33-13-12-32(25(33)34)17-5-7-18(8-6-17)37(2,35)36/h4-11,14-15H,3,12-13H2,1-2H3,(H2,27,28,29)
InChIKeyKRFRUXMQJFZJFO-UHFFFAOYSA-N
MW521.58 g/mol
LogP3.60
Rot. Bonds6

About 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one

1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one (PubChem CID 90326598) has the molecular formula C25H24FN7O3S and a molecular weight of 521.58 g/mol. Its IUPAC name is 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one.

Molecular Properties

Compound Name1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one
PubChem CID90326598
Molecular FormulaC25H24FN7O3S
Molecular Weight521.58 g/mol
Exact Mass521.16
IUPAC Name1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one
SMILESCCn1cc(-c2ccc(F)c(N3CCN(c4ccc(S(C)(=O)=O)cc4)C3=O)c2)c(-c2ccnc(N)n2)n1
InChIInChI=1S/C25H24FN7O3S/c1-3-31-15-19(23(30-31)21-10-11-28-24(27)29-21)16-4-9-20(26)22(14-16)33-13-12-32(25(33)34)17-5-7-18(8-6-17)37(2,35)36/h4-11,14-15H,3,12-13H2,1-2H3,(H2,27,28,29)
InChIKeyKRFRUXMQJFZJFO-UHFFFAOYSA-N
XLogP3.60
TPSA127.31 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500521.58
LogP ≤ 53.60
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one?
The IUPAC name of 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one (CID 90326598) is 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one.
What is the SMILES notation for 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one?
The canonical SMILES for 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one is CCn1cc(-c2ccc(F)c(N3CCN(c4ccc(S(C)(=O)=O)cc4)C3=O)c2)c(-c2ccnc(N)n2)n1.
What is the InChIKey of 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one?
The InChIKey is KRFRUXMQJFZJFO-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H24FN7O3S/c1-3-31-15-19(23(30-31)21-10-11-28-24(27)29-21)16-4-9-20(26)22(14-16)33-13-12-32(25(33)34)17-5-7-18(8-6-17)37(2,35)36/h4-11,14-15H,3,12-13H2,1-2H3,(H2,27,28,29).
What are the key properties of 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one?
1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one has a molecular weight of 521.58 g/mol, XLogP of 3.60, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[5-[3-(2-aminopyrimidin-4-yl)-1-ethylpyrazol-4-yl]-2-fluorophenyl]-3-(4-methylsulfonylphenyl)imidazolidin-2-one is sourced from PubChem (CID 90326598), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).